| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/16/1993 | US5187154 Administering cholecystokinins |
| 02/16/1993 | US5187153 Methods of treatment using Alzheimer's amyloid polypeptide derivatives |
| 02/16/1993 | US5187151 Use of binding protein with igf-i as an anabolic growth promoting agent |
| 02/16/1993 | US5187089 Variants wherein there are nonpolar amino acid substitutions at the substrate binding site |
| 02/16/1993 | US5187087 Recominbant herpesvirus of turkeys and live vector vaccines derived thereof |
| 02/16/1993 | US5187080 For inducing immune response in chickens |
| 02/16/1993 | US5187077 Leukaemia inhibitory factor |
| 02/16/1993 | US5187076 DNA sequences encoding BMP-6 proteins |
| 02/16/1993 | US5187075 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
| 02/16/1993 | US5187063 Combining a muscle sample with antibodies which specifically bind to glycoprotein component of dystrophin/glycoprotein complex, detecing extent of binding and comparing with extent of binding in nondystrophic muscle tissue samples |
| 02/16/1993 | US5186931 Composition and method for supporting bone marrow transplantation |
| 02/16/1993 | CA1313725C Crystalline l-carnosine zinc complex and production thereof |
| 02/16/1993 | CA1313724C Aminoacid derivatives as antihypertensives |
| 02/16/1993 | CA1313602C Flour, bread, milk, and other products from white sweet potatoes, cassava, edible aroids, amaranth, yams, and lotus |
| 02/15/1993 | CA2076064A1 Derivatives of human haemoglobin, method for preparing them, products derived therefrom and use of these derivatives and products |
| 02/13/1993 | CA2075671A1 Treatment of congestive heart failure |
| 02/11/1993 | DE4232594A1 Use of endorphin(s) - for treating migraine and chronic joint rheumatism |
| 02/11/1993 | DE4125933A1 Verbesserung der regeneration von oligodendrocyten Improve the regeneration of oligodendrocytes |
| 02/11/1993 | CA2075547A1 Trifluoromethyl-containing pseudopeptides |
| 02/10/1993 | EP0527069A1 Derivatives of pyrrolidine and thiazolidine, their preparation, and pharmaceutical compositions containing them |
| 02/10/1993 | EP0527056A1 Novel reagent for tumour imaging and therapy |
| 02/10/1993 | EP0526953A1 Multichain polypeptides or proteins and processes for their production |
| 02/10/1993 | EP0526952A2 Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same |
| 02/10/1993 | EP0526905A2 Multimers of the soluble forms of TNF receptors, their preparation and pharmaceutical compositions containing them |
| 02/10/1993 | EP0526888A2 Monoclonal antibody reactive with human pancreas cancer tissue |
| 02/10/1993 | EP0526877A2 Peptide aldehydes as antithrombotic agents |
| 02/10/1993 | EP0526756A1 Composition for revitalizing scar tissue |
| 02/10/1993 | EP0526630A1 Use of gm-csf and g-csf to promote accelerated wound healing |
| 02/10/1993 | EP0526608A1 Therapeutic agents for the treatment of multidrug resistance to cancers. |
| 02/10/1993 | EP0526570A1 Composition and treatment with biologically active peptides and anti-parasitic agents or anti-fungal agents |
| 02/10/1993 | EP0526544A1 Therapeutic uses of actin-binding compounds |
| 02/10/1993 | EP0526452A1 Hybrid immunoglobulins |
| 02/10/1993 | EP0402415B1 Synthetic scm-active cancer recognition peptides |
| 02/10/1993 | EP0167548B1 Cloning of cdna and expression of murine-interleukin-3 |
| 02/10/1993 | CN1068744A Asialoglycoprotein-conjugated medicinal agent |
| 02/09/1993 | WO1993002697A1 Production of peptide amides |
| 02/09/1993 | US5185441 Polypeptides that bind to CD2, the receptor on the surface of T-cells |
| 02/09/1993 | US5185432 Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas |
| 02/09/1993 | US5185431 Isolated, purified glyoprotein factor having antitumor activity |
| 02/09/1993 | US5185430 Protein isolated from surface of mammalian or fish cells |
| 02/09/1993 | US5185324 Enzyme-inhibiting amino acid derivatives, a process for the preparation thereof, agents containing these, and the use thereof |
| 02/09/1993 | US5185323 Administering to reduce number of circulating platelets in bloodstream of mammals |
| 02/09/1993 | US5185321 Adding lysozyme to Lactobeicillus, incubating, hydrolyzing peptidoglycans, centriguging, adding to whey or fermented milk |
| 02/09/1993 | US5185319 Administering a mixture of insulin and a 30hydroxypyrid-4-one |
| 02/09/1993 | US5185259 Recombinant human tissue plasminogen activator of high purity |
| 02/09/1993 | US5185254 Gene family of tumor-associated antigens |
| 02/09/1993 | US5185149 Intravenously administering an acyloxiranecarboxylic acid compound factor XIII inhibitor to lyse clots |
| 02/09/1993 | CA2115159A1 Production of peptide amides |
| 02/09/1993 | CA2074700A1 Isolation and structure of the cell growth inhibitory cycloheptapeptide axinastatin 1 |
| 02/09/1993 | CA2014033C Compositions and treatments for pneumonia in animals |
| 02/08/1993 | CA2075328A1 Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines |
| 02/07/1993 | CA2075343A1 Monoclonal antibody and uses of the same |
| 02/07/1993 | CA2075154A1 Peptide aldehydes as antithrombotic agents |
| 02/04/1993 | WO1993002209A1 Methods of designing specific affectors using three-dimensional conformation of enzyme/affector complex |
| 02/04/1993 | WO1993002206A1 Purification of recombinant ciliary neurotrophic factor and c-terminal truncated ciliary neurotrophic factor and methods for treating peripheral nerve damage |
| 02/04/1993 | WO1993002205A1 Substance with anti-tumour action produced from macrophages |
| 02/04/1993 | WO1993002192A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | WO1993002191A1 Humanized antibody against cd18 |
| 02/04/1993 | WO1993002188A1 Universal donor cells |
| 02/04/1993 | WO1993002186A1 Bacterial esterase for cocaine detection |
| 02/04/1993 | WO1993002108A1 Recombinant antibodies for human therapy |
| 02/04/1993 | WO1993002106A1 Neural calcium-activated neutral proteinase inhibitors |
| 02/04/1993 | WO1993002105A1 Trifunctional compounds having specificity for multi-drug resistant cells |
| 02/04/1993 | WO1993002099A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 02/04/1993 | WO1993001834A1 Synergistic antibody composition |
| 02/04/1993 | WO1993001830A1 Expression of enzymatically active recombinant human acetylcholinesterase and uses thereof |
| 02/04/1993 | WO1993001829A1 Antibiotic feed compositions and method of enhancing feed efficiency and promoting growth in monogastic animals |
| 02/04/1993 | WO1993001828A1 Lipid conjugates of therapeutic peptides and protease inhibitors |
| 02/04/1993 | WO1993001827A1 Osteoclast growth regulatory factor |
| 02/04/1993 | WO1993001826A1 Method of treating asthma |
| 02/04/1993 | WO1993001825A1 Antitumor drug |
| 02/04/1993 | WO1993001824A1 Combination therapy using bioflavonoid compounds with anti-cancer drugs |
| 02/04/1993 | WO1993001820A2 Inhibition of non-cd4 mediated hiv infection |
| 02/04/1993 | WO1993001802A1 Composition for the sustained and controlled release of a medicinal peptide-containing substance, and preparation method therefor |
| 02/04/1993 | WO1993001800A1 Therapeutic compositions and methods |
| 02/04/1993 | WO1993001723A1 Prophylaxis and treatment of adverse oral conditions with biologically active peptides |
| 02/04/1993 | WO1992013950A3 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/04/1993 | DE4224050A1 Loesliche kit-liganden Soluble kit ligand |
| 02/04/1993 | DE4125400A1 Verwendung von kollagen zur behandlung von degenerativen gelenkprozessen Use of collagen for the treatment of degenerative joint processes |
| 02/04/1993 | DE4125393A1 Verwendung von kollagen zur prophylaxe von herpes labialis-infektionen Use of prophylaxis of herpes labialis collagen to infections |
| 02/04/1993 | CA2114140A1 Antibiotic feed compositions and method of enhancing feed efficiency and promoting growth in monogastic animals |
| 02/04/1993 | CA2114122A1 Therapeutic compositions and methods |
| 02/04/1993 | CA2113828A1 Osteoclast growth regulatory factor |
| 02/04/1993 | CA2113815A1 Purification of recombinant ciliary neurotrophic factor and c-terminal truncated ciliary neurotrophic factor and methods for treating peripheral nerve damage |
| 02/04/1993 | CA2113578A1 Trifunctional compounds having specificity for multi-drug resistant cells |
| 02/04/1993 | CA2113358A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 02/04/1993 | CA2113206A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | CA2113202A1 Neural calcium-activated neutral proteinase inhibitors |
| 02/04/1993 | CA2113156A1 Lipid conjugates of therapeutic peptides and protease inhibitors |
| 02/03/1993 | EP0526258A2 A87689 Compounds, their production and use as phospholipase-A2 inhibitors |
| 02/03/1993 | EP0526192A2 Hexapeptide |
| 02/03/1993 | EP0526009A1 Inhibitors of hiv protease useful for the treatment of aids |
| 02/03/1993 | EP0525992A2 Cluster conjugates of drugs with antibodies |
| 02/03/1993 | EP0525917A2 Double-stranded RNA correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles |
| 02/03/1993 | EP0525838A2 Growth hormone releasing factor analogs |
| 02/03/1993 | EP0525813A1 Water-soluble composition for sustained-release |
| 02/03/1993 | EP0525570A2 Anti-idiotypic antibodies that mimic TNF |
| 02/03/1993 | EP0525502A1 Method for the preparation of virus-inactivated immunoglobuline solutions |
| 02/03/1993 | EP0525499A1 Amide derivatives of antibiotic A 40926 |
| 02/03/1993 | EP0525420A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors |